BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 131365)

  • 21. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
    Altman RD; Johnston CC; Khairi MR; Wellman H; Serafini AN; Sankey RR
    N Engl J Med; 1973 Dec; 289(26):1379-84. PubMed ID: 4201876
    [No Abstract]   [Full Text] [Related]  

  • 22. Paget's bone disease treated with diphosphonate and calcitonin.
    Hosking DJ; Bijvoet OL; van Aken J; Will EJ
    Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duration of effect of oral diphosphonate therapy in Paget's disease of bone.
    Gray RE; Yates AJ; Preston CJ; Smith R; Russell RG; Kanis JA
    Q J Med; 1987 Sep; 64(245):755-67. PubMed ID: 2966965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
    Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of disodium etidronate on Paget's disease of bone.
    Muir HG; Schabort I; Hough FS
    S Afr Med J; 1987 Oct; 72(7):470-2. PubMed ID: 3116683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of etidronate (EHDP) in Paget's disease of bone.
    Johnston CC; Khairi MR; Meunier PJ
    Arthritis Rheum; 1980 Oct; 23(10):1172-6. PubMed ID: 6775643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diphosphonates in Paget's disease.
    Russell RG; Smith R; Preston C; Walton RJ; Woods CG
    Lancet; 1974 May; 1(7863):894-8. PubMed ID: 4133419
    [No Abstract]   [Full Text] [Related]  

  • 28. Mithramycin treatment of Paget's disease of bone. Exploration of combined mithramycin-EHDP therapy.
    Ryan WG; Schwartz TB
    Arthritis Rheum; 1980 Oct; 23(10):1155-61. PubMed ID: 6158957
    [No Abstract]   [Full Text] [Related]  

  • 29. [Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
    Sieghart S
    Wien Med Wochenschr; 1986 Nov; 136(21-22):583-5. PubMed ID: 3103338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoporosis, osteomalacia, rickets, and Paget's disease.
    Nugent CA; Gall EP; Pitt MJ
    Prim Care; 1984 Jun; 11(2):353-68. PubMed ID: 6236469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Paget's disease of bone.
    Singer FR
    Postgrad Med; 1975 Mar; 57(3):117-20. PubMed ID: 123333
    [No Abstract]   [Full Text] [Related]  

  • 32. Paget's disease of bone: assessment and management.
    Ibbertson HK; Fraser TR; Scott DJ; Cullen JC; Henley JW; Stephens ES; Tait B; Wattie DJ
    Drugs; 1979 Jul; 18(1):33-47. PubMed ID: 157870
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.
    Siris E; Weinstein RS; Altman R; Conte JM; Favus M; Lombardi A; Lyles K; McIlwain H; Murphy WA; Reda C; Rude R; Seton M; Tiegs R; Thompson D; Tucci JR; Yates AJ; Zimering M
    J Clin Endocrinol Metab; 1996 Mar; 81(3):961-7. PubMed ID: 8772558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective short term treatment of Paget's disease with oral etidronate.
    Preston CJ; Yates AJ; Beneton MN; Russell RG; Gray RE; Smith R; Kanis JA
    Br Med J (Clin Res Ed); 1986 Jan; 292(6513):79-80. PubMed ID: 3080099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paget's disease and the nervous system.
    Feldman RG; Culebras A; Schmidek HH
    J Am Geriatr Soc; 1979 Jan; 27(1):1-8. PubMed ID: 215614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.
    Ralston SH; Boyce BF; Cowan RA; Fogelman I; Smith ML; Jenkins A; Boyle IT
    J Bone Miner Res; 1987 Feb; 2(1):5-12. PubMed ID: 3137773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term follow-up of 88 patients with Paget's disease treated by discontinuous courses of low-dose disodium etidronate].
    Ravault A; Meunier PJ
    Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):293-302. PubMed ID: 2496461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mithramycin in Paget's disease.
    Epstein S
    S Afr Med J; 1974 Jun; 48(31):1328-30. PubMed ID: 4276946
    [No Abstract]   [Full Text] [Related]  

  • 39. Paget's disease of bone: problems and management.
    Haddad JG
    Orthop Clin North Am; 1972 Nov; 3(3):775-86. PubMed ID: 4344935
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of Paget's disease with phosphonates].
    Reiner M; Jung A; Seiler A; Schenk R; Fleisch H
    Schweiz Med Wochenschr; 1975 Dec; 105(50):1701-3. PubMed ID: 1215960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.